Curaleaf (CURLF) has been one of the big beneficiaries of the latest cannabis fervor. CURLF stock has climbed roughly 80% year to date and up more than 230% over the past three months as traders price in a possible federal rescheduling tailwind and the company’s steady push to stabilize operations.
Curaleaf consistently stands out for investors tracking multi-state operators (MSOs). Its expansive U.S. retail footprint, broad product lineup, and growing international presence position it as a top pick when policy risks begin to ease and speculative capital flows back into the sector.
